Modulation of Urate Transport by Drugs
Background: Serum urate (SU) levels in primates are extraordinarily high among mammals. Urate is a Janus-faced molecule that acts physiologically as a protective antioxidant but provokes inflammation and gout when it precipitates at high concentrations. Transporters play crucial roles in urate dispo...
Main Authors: | Péter Tátrai, Franciska Erdő, Gabriella Dörnyei, Péter Krajcsi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/6/899 |
Similar Items
-
Variation of Urate Transport in the Nephrons in Subtypes of Hyperuricemia
by: Toru Nakamura, et al.
Published: (2013-08-01) -
A Novel Multi-Epitope Vaccine Based on Urate Transporter 1 Alleviates Streptozotocin-Induced Diabetes by Producing Anti-URAT1 Antibody and an Immunomodulatory Effect in C57BL/6J Mice
by: Yanjie Ma, et al.
Published: (2017-10-01) -
Two cases of acute urate nephropathy in women with asymptomatic hyperuricemia
by: L. N. Yeliseyeva, et al.
Published: (2021-03-01) -
Anti-Hyperuricemic Effects of Astaxanthin by Regulating Xanthine Oxidase, Adenosine Deaminase and Urate Transporters in Rats
by: Yanzuo Le, et al.
Published: (2020-12-01) -
Uric acid transporter inhibitors for gout
by: Philip K. Tan, et al.
Published: (2017-06-01)